Recruiting
Phase 1

Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)

Sponsor:

EMD Serono Research & Development Institute, Inc.

Code:

NCT05464030

Conditions

Colorectal Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

M9140

M9140

Bevacizumab

Capecitabine

5-fluorouracil (5-FU)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information